Navigation Links
Zoe Saldana Declares "I'd have Botox"
Date:5/3/2013

Los Angeles, California (PRWEB) May 03, 2013

On May 1, 2013 the Belfast Telegraph reported on Zoe Saldana’s interview in the latest UK edition of InStyle magazine. Ms. Saldana, the star of James Cameron’s Avatar and the soon to be released Star Trek Into Darkness, sat down with the magazine and revealed how she felt about growing older and the movie industry. Ms. Saldana says that she do Botox and wouldn’t hesitate to have cosmetic surgery. (go to goo.gl/B4m9t)

“I truly admire any public figure that is willing to come out and openly declare that they’re willing to talk about growing older and addressing the signs of aging,” says Dr. Simon Ourian, Medical Director of Epione Hills. “I think it’s perfectly normal to want to look as good as we feel. I have numerous celebrity clients and they generally try to maintain their privacy about the treatments we provide.”

Ms. Saldana is quoted in the article as saying that "It scares me that there are so many women unhappy with themselves, ashamed of themselves, of ageing, of being who they are. Because the only reason they're hiding it is because they're afraid of rejection or judgment. That's external. You can reject me all you want, I'm OK with it. You can judge me all you want, I'm OK with myself." (go to goo.gl/B4m9t)

“I especially admire that Ms. Saldana appears to speaking from a healthy sense of self,” says Dr. Ourian. “It appears to me that should she ever opt to have an aesthetic treatment it would be for herself and not to make someone else happy.”

Dr. Ourian has been a pioneer in laser technology and non-invasive aesthetic procedures including Restylane, Juvéderm, Radiesse and Sculptra. These treatments are used for the correction or reversal of a variety of conditions such as acne, acne scars, skin discoloration, wrinkles, stretch marks, varicose veins, cellulite, and others. More information about Botox can be found on Epione’s website.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10678679.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. SkilletsAndMore.Com Declares April As Not For Profit Sponsoring Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... ... CloudLIMS, joins an elite number of companies that have earned a spot on ... CIOReview. , In a deliberate session with the honorary industrial experts, a list of ... with. The positioning is based on evaluation of CloudLIMS’ specialties in Automated Sample Management ...
(Date:5/25/2016)... ... 25, 2016 , ... DKT International, one of the largest ... pleased to release their 2015 global impact data. In 2015, DKT served over ... deaths and 3.8 million unsafe abortions across 21 countries worldwide. , “We ...
(Date:5/25/2016)... Mexico (PRWEB) , ... May 25, 2016 , ... Casa ... the restorative properties of precious stones to complement its new wellness suites . ... two floors and feature a plethora of special services and insuite amenities, from a ...
(Date:5/25/2016)... ... ... more than fifty years, we've suffered whiplash as each new scientific study seemed to contradict ... nutritional advice – advice that was supposed to keep us healthy and slim. And what ... are considered to be overweight and more than 1 in 3 adults are considered to ...
(Date:5/25/2016)... ... 25, 2016 , ... Researchers from SUNY State College of Optometry won the ... visual evoked potential and human attention. The article, VEP and Human Attention: Translation ... ERG and VEP Vision Testing System (Diopsys, Inc., Pine Brook, NJ) to record ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)...   , Study met both ... in , Excellent plus Good ... of the ascending colon   ,      ... announced new positive data from the phase III MORA study for ... litre PEG with ascorbate. The study met both primary endpoints showing ...
(Date:5/24/2016)... 2016 ARANZ Medical  Ltd a ... sector, has been named the Coretex Hi-Tech Emerging Company of ... Dr Bruce Davey , CEO of ARANZ Medical ... really good to be recognised for the work we are ... used in 35 countries around the world from Sub-Saharan Africa ...
(Date:5/24/2016)... 2016 Celsion Corporation (NASDAQ: ... provided an update on its ongoing OVATION study, ... GEN-1, the Company,s DNA-based immunotherapy, with the standard ... with advanced ovarian cancer who will undergo neoadjuvant ... an IL-12 DNA plasmid vector formulated as a ...
Breaking Medicine Technology: